Tender Title: ONCO DRUGS
Tender Reference Number: bd3e2461
Issuing Authority:
Department of Military Affairs, Ministry of Defence
Scope of Work and Objectives:
The primary objective of this tender is to procure a comprehensive range of oncology drugs, specifically focusing on the supply of 20 percentage Urea with Pentavitin cream (50ml) and Inj Bleomycin Sulphate oblique Chloride (15). This tender seeks to ensure the availability of critical medications for military healthcare facilities, which play a vital role in addressing cancer treatment needs for personnel and their dependents. The successful bidder will be required to supply a total quantity of 90,930 units across the specified categories.
Eligibility Criteria:
To be eligible for bidding, participants must fulfill the following criteria:
- Must be a registered entity in India.
- Must possess the necessary licenses for drug manufacturing and distribution as per regulatory requirements.
- Experience in the supply of oncology drugs with at least one year of proven track record.
- Compliance with quality and safety standards as mandated by applicable laws.
Technical Requirements:
Bidders must provide comprehensive technical documentation that demonstrates:
- Compliance with the Indian Pharmacopoeia standards for oncology drugs.
- Stability and efficacy data for the products being offered.
- Batch release certificates from authorized quality control laboratories.
Financial Requirements:
Bidders must demonstrate their financial viability by providing:
- Audited financial statements for the last two years.
- Details on funding mechanisms to support the timely production and supply of the drugs.
Document Submission Details:
All tender submissions must be duly completed and sent to the designated procurement office of the Department of Military Affairs. Bidders are expected to follow the prescribed “two-bid system,” which includes both technical and financial bids submitted separately. Electronic submissions may be accepted as per the guidelines provided in the tender documentation.
Special Provisions:
The tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and offers benefits such as:
- Preference in bid evaluation.
- Relaxation in eligibility criteria where applicable.
Startups in the pharmaceutical sector are also encouraged to participate to promote innovation and growth within the industry.
Evaluation Process:
The evaluation of bids will be executed through a meticulous process that reviews both technical and financial components. The evaluation criteria will focus on:
- Comprehensiveness of the technical proposals.
- Pricing strategies and total cost of ownership implications.
- Compliance with the prescribed delivery timelines.
Delivery Locations:
The successful bidder will be responsible for delivering the drugs to specified military healthcare facilities across various locations as indicated in the tender documents.
Contact Information:
For any inquiries or clarifications regarding this tender, please consult the contact details provided in the official tender documentation.
Additional Information:
Bidders are strongly advised to read the tender guidelines thoroughly and ensure their submissions comply fully with all stipulations to enhance their chances of securing the contract.
Tender BOQ Items
79 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
7 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, possessing the necessary drug manufacturing licenses, and demonstrating a proven record in supplying oncology drugs. Bidders must also comply with applicable quality standards and safety regulations. Preference will be given to Micro, Small, and Medium Enterprises (MSEs) to support their participation in the bidding process.
Bidders must submit a variety of certificates, including valid drug manufacturing licenses from the Drug Control Authority, ISO certifications demonstrating compliance with quality management systems, and batch release certificates for the offered products to ensure compliance with safety and efficacy standards.
The registration process requires bidders to fill in the necessary application forms, submit pertinent documents such as corporate registration and compliance certificates, and pay any applicable fees as specified in the tender guidelines. Further instructions will be made available in the tender documentation.
The “Earnest Money Deposit (EMD)” is a security deposit required to affirm the seriousness of the bidder. Details regarding the specific EMD amount and accepted payment methods will be outlined in the tender documentation, which bidders should carefully review to ensure compliance.
Yes, the tender includes special provisions to encourage startups in the pharmaceutical sector, such as easing eligibility criteria and providing opportunities for longer validation periods. Startups are invited to leverage these advantages to compete effectively within the tender.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders